William McDowall Wells, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 15,000 shares at $23.03 ($345K) on 2014-06-09, disclosed to the SEC on 2014-06-10.
Scheduled sale ($345k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VRX | SELL | 2010-12-08 | $14.3M | — | Filing → |
| VRX | SELL | 2010-11-12 | $9.7M | — | Filing → |